SARS-CoV-2 mAbs Continued to Be Used After FDA Deauthorization
TUESDAY, Aug. 30, 2022 (HealthDay News) — More than 158,000 doses of two anti-severe acute respiratory syndrome coronavirus 2 monoclonal antibodies (mAbs), bamlanivimab-etesevimab and casirivimab-imdevimab, were administered in early 2022, despite de…
Learn MoreDuration of Infectiousness Examined in COVID-19 Cases
TUESDAY, Aug. 30, 2022 (HealthDay News) — Twenty percent of COVID-19 cases shed infectious virus before symptom onset, according to a study published online Aug. 18 in The Lancet Respiratory Medicine.
Seran Hakki, Ph.D., from Imperial College Londo…
Learn MoreFirst U.S. Monkeypox Death Reported in Texas
TUESDAY, Aug. 30, 2022 (HealthDay News) — A Texas patient who was infected with monkeypox has died, though state health officials said Tuesday it is too early to say what role the virus may have played in the death.
The adult, who died in a hospital …
Miles de pacientes de EE. UU. recibieron unos tratamientos para la COVID que la FDA rechazó por inútiles
LUNES, 29 de agosto de 2022 (HealthDay News) — Los médicos de EE. UU. administraron más de 150,000 dosis de tratamientos de anticuerpos monoclonales inútiles a pacientes con COVID-19 a principios del año, gastando mucho dinero en terapias que se ha d…
Learn MoreLos hombres negros tienen menos probabilidades de recibir la vacuna contra la viruela del simio
LUNES, 29 de agosto de 2022 (HealthDay News) — Aunque ahora hay suficiente vacuna contra la viruela del simio para todo el mundo, los estadounidenses que más la necesitan quizá no la estén recibiendo, muestra un nuevo informe.Apenas un 10 por ciento …
Learn MoreFirst U.S. Monkeypox Death Reported in Texas
TUESDAY, Aug. 30, 2022 (HealthDay News) — A Texas patient who was infected with monkeypox has died, though state health officials said Tuesday it’s too early to say what role the virus may have played in the death. The adult, who died in a hospital i…
Learn MoreSchool-Aged Children Can Self-Swab for COVID-19 Testing
TUESDAY, Aug. 30, 2022 (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in nasal swabs that are self-collected by school-aged children and adolescents shows high agreement with results collected by health care…
Learn MoreSmall Study Supports TPOXX as Monkeypox Treatment
TUESDAY, Aug. 30, 2022 (HealthDay News) — The drug tecovirimat appears to be safe and effective for treating the symptoms and skin lesions of monkeypox, a small study suggests.Tecovirimat (TPOXX) is an antiviral drug for the treatment of smallpox. It…
Learn MoreCOVID Vaccine Won’t Raise Stroke Risk
TUESDAY, Aug. 30, 2022 (HealthDay News) — COVID-19 vaccines do not increase your risk for stroke, new research shows, but severe COVID infection does, and experts hope the finding will ease the concerns of those who are hesitant to get the shot.“We n…
Learn MoreMen Who Have Sex With Men Acting to Prevent Monkeypox Transmission
MONDAY, Aug. 29, 2022 (HealthDay News) — Gay, bisexual, and other men who have sex with men (MSM) are taking actions to reduce their risk for acquiring the monkeypox virus, according to research published in the Aug. 26 early-release issue of the …
Learn More